2012 ©
             Publication
Journal Publication
Title of Article Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey 
Date of Acceptance 15 February 2023 
Journal
     Title of Journal International Journal of Environmental Research and Public Health 
     Standard ISI 
     Institute of Journal Multidisciplinary Digital Publishing Institute (MDPI) 
     ISBN/ISSN  
     Volume 20 
     Issue
     Month February
     Year of Publication 2023 
     Page 3725 
     Abstract Adverse drug reaction (ADR) severity levels are mainly rated by healthcare professionals (HCPs), but patient ratings are limited. This study aimed to compare patient-rated and pharmacistrated ADR severity levels and determined methods employed for ADR management and prevention by patients and HCPs. A cross-sectional survey was conducted in outpatients visiting two hospitals. Patients were asked about ADR experiences using a self-administered questionnaire, and additional information was retrieved from the medical records. In total, 617 out of 5594 patients had experienced ADRs (11.0%), but 419 patients were valid (68.0%). Patients commonly reported that their ADR severity level was moderate (39.4%), whereas pharmacists rated the ADRs as mild (52.5%). There was little agreement between patient-rated and pharmacist-rated ADR severity levels (kappa = 0.144; p < 0.001). The major method of ADR management by physicians was drug withdrawal (84.7%), while for patients, it was physician consultation (67.5%). The main methods for ADR prevention by patients and HCPs were carrying an allergy card (37.2%) and recording drug allergy history (51.1%), respectively. A higher level of ADR bothersomeness was associated with higher ADR severity levels (p < 0.001). Patients and HCPs rated ADR severity and used ADR management and prevention methods differently. However, patient rating of ADR severity is a potential signal for severe ADR detection of HCPs. 
     Keyword patient self-reporting; adverse drug reactions; severity; management; prevention 
Author
617150007-4 Mrs. WARISARA SRISURIYACHANCHAI [Main Author]
Pharmaceutical Sciences Doctoral Degree

Reviewing Status มีผู้ประเมินอิสระ 
Status ได้รับการตอบรับให้ตีพิมพ์ 
Level of Publication นานาชาติ 
citation true 
Part of thesis true 
Attach file
Citation 0